Bay Colony Advisory Group, Inc D Glaukos Corp Transaction History

Bay Colony Advisory Group, Inc D

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Nov 02, 2021	SELL	$47.43 - $84.23 $157,277 - $279,306	-3,316 Closed	0 $0
Q2 2021 Jul 22, 2021	BUY	$73.06 - $97.7 $37,698 - $50,413	516 Added 18.43%	3,316 $281,000
Q1 2021 May 13, 2021	SELL	$70.43 - $97.42 $59,161 - $81,832	-840 Reduced 23.08%	2,800 $235,000
Q4 2020 Feb 02, 2021	SELL	$48.9 - $75.26 $51,785 - $79,700	-1,059 Reduced 22.54%	3,640 $274,000
Q3 2020 Nov 25, 2020	BUY	$37.23 - $50.97 $174,943 - $239,508	4,699 New	4,699 $233,000

341

46.8M

132K

188K

Ticker GKOS
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 47,596,900
Market Cap $7.2B
Description
Glaukos Corporation, an ophthalmic medical technology and pharmaceutical company, focuses on the development of novel therapies for the treatment of glaucoma, corneal disorders, and retinal diseases. It offers iStent, iStent inject, iStent inject W micro-bypass stents that enhance aqueous humor outflow inserted in cataract surgery to treat mild-...

Get notified when there are updates to the investment portfolio of Bay Colony Advisory Group, Inc D, based on Form 13F filings with the SEC.

Stay updated on Bay Colony Advisory Group, Inc D with notifications on news.